Cargando…
T-Cell Therapy: Options for Infectious Diseases
The emergence of drug-resistant tuberculosis is challenging tuberculosis control worldwide. In the absence of an effective vaccine to prevent primary infection with Mycobacterium tuberculosis and tuberculosis disease, host-directed therapies may offer therapeutic options, particularly for patients w...
Autores principales: | Parida, Shreemanta K., Poiret, Thomas, Zhenjiang, Liu, Meng, Qingda, Heyckendorf, Jan, Lange, Christoph, Ambati, Aditya S., Rao, Martin V., Valentini, Davide, Ferrara, Giovanni, Rangelova, Elena, Dodoo, Ernest, Zumla, Alimuddin, Maeurer, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583575/ https://www.ncbi.nlm.nih.gov/pubmed/26409284 http://dx.doi.org/10.1093/cid/civ615 |
Ejemplares similares
-
B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis
por: Rao, Martin, et al.
Publicado: (2015) -
Use of the Xpert® MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia
por: Bates, Matthew, et al.
Publicado: (2013) -
IL-2, IL-15 and IL-21 expand T cells for targeted adoptive therapy
por: Liu, Zhenjiang, et al.
Publicado: (2015) -
Enhanced tumor-infiltrating lymphocytes (eTIL) for cellular therapy of patients with pancreatic cancer or glioblastoma
por: Meng, Qingda, et al.
Publicado: (2015) -
A fast assay to gauge for TAA-reactive T cells in PBMCS from patients with pancreatic cancer
por: Rangelova, Elena B, et al.
Publicado: (2014)